Alerts will be sent to your verified email
Verify EmailFREDUN
|
Fredun Pharma
|
Jagsonpal Pharma
|
Syncom Formulations
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
12.85 % | 16.01 % | 9.79 % |
|
5yr average Equity Multiplier
|
2.76 | 1.27 | 1.41 |
|
5yr Average Asset Turnover Ratio
|
1.02 | 1.09 | 0.81 |
|
5yr Avg Net Profit Margin
|
4.66 % | 12.08 % | 8.78 % |
|
Price to Book
|
5.33 | 5.31 | 3.15 |
|
P/E
|
45.45 | 34.04 | 17.09 |
|
5yr Avg Cash Conversion Cycle
|
130.49 Days | 2.39 Days | 61.57 Days |
|
Inventory Days
|
169.92 Days | 31.56 Days | 27.32 Days |
|
Days Receivable
|
77.49 Days | 15.63 Days | 82.75 Days |
|
Days Payable
|
112.96 Days | 59.94 Days | 79.41 Days |
|
5yr Average Interest Coverage Ratio
|
2.33 | 66.99 | 31.44 |
|
5yr Avg ROCE
|
27.08 % | 18.99 % | 13.63 % |
|
5yr Avg Operating Profit Margin
|
12.26 % | 13.23 % | 9.97 % |
|
5 yr average Debt to Equity
|
0.95 | 0.01 | 0.19 |
|
5yr CAGR Net Profit
|
15.87 % | 26.54 % | 36.24 % |
|
5yr Average Return on Assets
|
4.74 % | 12.71 % | 7.11 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.17 % | 67.89 % | 50.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.98 % | -0.82 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fredun Pharma
|
Jagsonpal Pharma
|
Syncom Formulations
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|